Telix Pharmaceuticals Ltd
ASX:TLX
Telix Pharmaceuticals Ltd
ASX:TLX
Price:
8.82
AUD
2.2%
Market Closed
Market Cap:
AU$3B
Relative Value
The Relative Value of one
TLX
stock under the Base Case scenario is
hidden
AUD.
Compared to the current market price of 8.82 AUD,
Telix Pharmaceuticals Ltd
is
hidden
.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TLX Relative Value
HIDDEN
Multiples Across Competitors
TLX Competitors Multiples
Telix Pharmaceuticals Ltd Competitors
Telix Pharmaceuticals Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| AU |
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
3B AUD | 4.5 | 275.1 | 113.5 | 113.5 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 643 258.8 | -159 901.4 | -194 171.3 | -191 955.6 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
409.9B USD | 6.9 | 174.7 | 16.8 | 23.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
200B USD | 5.4 | 25.9 | 14.9 | 14.9 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
192.3B USD | 6.5 | 22.4 | 15.2 | 15.2 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.3B USD | 10.2 | 31.1 | 23.8 | 24.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 094 | -534.3 | -581.8 | -566.3 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.1B USD | 5.8 | 18.6 | 14.1 | 16.1 | |
| AU |
|
CSL Ltd
ASX:CSL
|
72.9B AUD | 3.3 | 17 | 11.6 | 14.5 | |
| NL |
|
argenx SE
XBRU:ARGX
|
42.7B EUR | 14.3 | 33.7 | 57.9 | 59.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.2 | -61.8 | -66.7 | -60.2 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
